Login to Your Account

Financings Roundup

Calistoga's Series B Adds $30M for p110 Delta PI3 Kinase Drugs

By Jennifer Boggs

Wednesday, May 6, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription